TELA Bio Inc. (TELA): Market Cap to Revenue

Symbol and logo of brand TELA Bio Corp (TELA)

TELA Bio, Inc. (TELA) maintains a moderate dependence on external CRO partners for biomaterial testing, which impacts the business valuation based on the P/S ratio. The robotization of soft tissue implant production and strict adherence to environmental waste disposal regulations stabilize the share price. This chart's indicator dynamics show that the value of 0.50 expresses the metric level, correlating market expectations with actual sales volume.

TELA TELA Bio Corp P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for TELA Bio, Inc. (TELA)

- share price and consensus valuation forecast:
Price Performance Chart telabio.com|TELA - Price Target Chart
- stock exchange capitalization data:
Market Valuation TELA Bio Corp|TELA - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share TELA Bio|TELA - Book Capitalization|Capitalization to Book Value Ratio telabio.com|TELA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient TELA Bio, Inc.|TELA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio telabio.com|TELA - Company Aggregate Debts|Debts to Book Capitalization TELA Bio Corp|TELA - Company Long-Term Debt|Company Short-Term Debt TELA Bio|Intermediate Coverage Ratio telabio.com
- earnings and multiples data:
TELA - Net Profit|Expected Net Profit TELA Bio, Inc.|TELA - Price to Earnings Ratio|Forward Price to Earnings Multiple telabio.com|TELA - Price/Earnings to Growth Multiple|EV/EBITDA Multiple TELA Bio Corp|TELA - Operating profit EBITDA|Net earnings per share for the last four quarters TELA Bio|TELA - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months telabio.com|TELA - Earnings per share growth in current year|Expected earnings per share growth for next year TELA Bio, Inc.
- issuer revenue and sales details:
TELA - Revenue and Sales Volume|Company Expected Sales Volume telabio.com|TELA - Price-to-Revenue Ratio|Market Cap to Projected Revenue TELA Bio Corp
General company analysis:TELA TELA Bio Inc.
Core merchandise of TELA Bio

The P/S ratio reflects the relationship between the market value of TELA Bio, Inc. (TELA) and its annual revenue, determining the premium the market is willing to pay per unit of sales. By analyzing the P/S chart, an investor assesses whether the rise in share price is supported by a real expansion of market share in the biosynthetic mesh segment. The reduction of complication risks protects margins, justifying the asset's high valuation. An imbalance between value and earnings signals an overbought risk.

Competitors of TELA Bio, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA (Profusa Inc) - Market Cap to Revenue|SSKN: Market Cap to Sales Volume|GCTK (GlucoTrack, Inc.) - P/S Multiple|Price to Sales nanovibronix.com NAOV|Price-to-Revenue Ratio Venus Concept Corp (VERO)|Price-to-Revenue Ratio NUWE (Nuwellis Corp)|P/S Multiple AEMD (Aethlon Medical)|P/S Multiple Asensus Surgical Inc ASXC|AVGR: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BSGM (BioSig)|CUTR: P/S Multiple|KNW (Know Labs Corporation) - Price-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|nevro.com (NVRO) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|SILK - Price to Sales